Is	is	O	O	O	O
phenytoin	phenytoin	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
safe	safe	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
hypothermic	hypothermic	O	O	OTHERS	I
child?A	child?a	O	O	O	O
male	male	O	O	O	O
neonate	neonate	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
Chiari	chiari	O	O	OTHERS	I
malformation	malformation	O	O	OTHERS	I
and	and	O	O	O	O
a	a	O	O	O	O
leaking	leaking	O	O	O	O
myelomeningocoele	myelomeningocoele	O	O	O	O
underwent	underwent	O	O	O	O
ventriculoperitoneal	ventriculoperitoneal	O	O	O	O
shunt	shunt	O	O	O	O
insertion	insertion	O	O	O	O
followed	followed	O	O	O	O
by	by	O	O	O	O
repair	repair	O	O	O	O
of	of	O	O	O	O
myelomeningocoele	myelomeningocoele	O	O	O	O
.	.	O	O	O	O

During	during	O	O	O	O
anaesthesia	anaesthesia	O	O	O	O
and	and	O	O	O	O
surgery	surgery	O	O	O	O
,	,	O	O	O	O
he	he	O	O	O	O
inadvertently	inadvertently	O	O	O	O
became	became	O	O	O	O
moderately	moderately	O	O	O	O
hypothermic	hypothermic	O	O	OTHERS	I
.	.	O	O	O	O

Intravenous	intravenous	O	O	O	O
phenytoin	phenytoin	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
administered	administered	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
later	later	O	O	O	O
part	part	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
surgery	surgery	O	O	O	O
for	for	O	O	O	O
seizure	seizure	O	DISEASE	OTHERS	I
prophylaxis	prophylaxis	O	O	O	O
.	.	O	O	O	O

Following	following	O	O	O	O
phenytoin	phenytoin	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
developed	developed	O	O	O	O
acute	acute	O	O	O	O
severe	severe	O	O	O	O
bradycardia	bradycardia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
refractory	refractory	O	O	O	O
to	to	O	O	O	O
atropine	atropine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
adrenaline	adrenaline	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
cardiac	cardiac	O	O	O	O
depressant	depressant	O	O	O	O
actions	actions	O	O	O	O
of	of	O	O	O	O
phenytoin	phenytoin	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
hypothermia	hypothermia	O	DISEASE	OTHERS	I
can	can	O	O	O	O
be	be	O	O	O	O
additive	additive	O	O	O	O
.	.	O	O	O	O

Administration	administration	O	O	O	O
of	of	O	O	O	O
phenytoin	phenytoin	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
hypothermia	hypothermia	O	DISEASE	OTHERS	I
may	may	O	O	O	O
lead	lead	O	O	OTHERS	I
to	to	O	O	O	O
an	an	O	O	O	O
adverse	adverse	O	O	O	O
cardiac	cardiac	O	O	O	O
event	event	O	O	O	O
in	in	O	O	O	O
children	children	O	O	O	O
.	.	O	O	O	O

As	as	O	O	O	O
phenytoin	phenytoin	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
commonly	commonly	O	O	O	O
used	used	O	O	O	O
drug	drug	O	O	O	O
,	,	O	O	O	O
clinicians	clinicians	O	O	O	O
need	need	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
aware	aware	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
interaction	interaction	O	O	O	O
.	.	O	O	O	O

